A detailed history of Strs Ohio transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 3,900 shares of VERA stock, worth $171,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,900
Previous 400 875.0%
Holding current value
$171,249
Previous $14,000 1128.57%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$34.09 - $46.71 $119,315 - $163,485
3,500 Added 875.0%
3,900 $172,000
Q2 2024

Aug 05, 2024

SELL
$33.72 - $48.82 $50,580 - $73,230
-1,500 Reduced 78.95%
400 $14,000
Q1 2024

May 13, 2024

BUY
$14.91 - $49.14 $8,946 - $29,484
600 Added 46.15%
1,900 $81,000
Q4 2023

Jan 30, 2024

BUY
$9.29 - $16.0 $12,076 - $20,800
1,300 New
1,300 $19,000
Q3 2021

Oct 22, 2021

BUY
$13.71 - $30.6 $21,936 - $48,960
1,600 New
1,600 $27,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.19B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.